Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Anaspec/SensoLyte ® 520 MMP - 13 Assay Kit *Fluorimetric*/1 kit/AS-71156188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Anaspec/SensoLyte ® 520 MMP - 13 Assay Kit *Fluorimetric*/1 kit/AS-71156

Description
Product NameSensoLyte ® 520 MMP - 13 Assay Kit *Fluorimetric*
Size1 kit
Catalog #AS-71156
US$$480

Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated proteins capable of digesting extracellular matrix components. MMP-13 (collagenase-3, rat collagenase) is involved in quite a few diseases such as arthritis and asthma. The SensoLyte® 520 MMP-13 Assay Kit uses a 5-FAM (fluorophore) and QXL® 520 (quencher) labeled FRET peptide substrates for continuous measurement of the enzyme activities. In an intact FRET peptide, the fluorescence of 5-FAM is quenched by QXL® 520. Upon the cleavage of the FRET peptide by MMP-13, the fluorescence of 5-FAM is recovered, and can be continuously monitored at excitation/emission = 490 nm/520 nm. With superior fluorescence quantum yield and longer emission wavelength, 5-FAM/QXL® 520 based FRET peptide is less interfered by the autofluorescence of test compounds and cellular components and provides better assay sensitivity. The assays are performed in a convenient 96-well or 384-well microplate format.Members of the MMP family have poor substrate sequence specificity, making it difficult to use a peptide substrate alone to differentiate the activity of a particular MMP from other MMPs. If several MMPs are coexisting in your samples and you would like to specifically measure MMP-13 activity, please choose the SensoLyte® Plus MMP-13 Assay Kit, Cat# 72019.

Kit size:100 assays

Detailed InformationDatasheet
Material Safety Data Sheets (MSDS)
Storage-20°C
Product CitationsWang, M. et al. (2013). MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Therapy 15, R5.Jaffré, F. et al. (2012). β-Adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells. Circulation 125, 2993. doi:10.1161/​CIRCULATIONAHA.111.066787Wigner, NA. et al. (2011). Urine matrix metalloproteinases (MMPSs) as biomarkers for the progression of fracture healing. Injury 10.1016/j.injury.2011.05.038.Madala, SK. et al. (2010). Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis. J Immunol 184, 3955.Bedi, A. et al. (2009). Doxycycline-mediated inhibition of matrix metalloproteinases improves healing after rotator cuff repair. Am J Sports Med 38, 308.Arnoczky, SP. et al. (2007). Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stress-deprived tendons: an in vitro experimental study. Am J Sports Med 35, 763.
新闻动态
行业前沿
技术文章
最新产品